SCHEMBL6159469

SCHEMBL6159469

Cc1cc(-c2ccc(F)cc2)ccc1N1CCN(CC(=O)c2ccccc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 3/20 0.51
HTT P42858 2/20 0.51
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAPT P10636 4/20 0.51
HPGD P15428 2/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C19 P33261 2/20 0.51
CYP2C9 P11712 1/20 0.51
HTR2A P28223 3/20 0.50
HTR2C P28335 2/20 0.50
SLC6A4 P31645 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HTR1A P08908 1/20 0.48
NSD2 O96028 1/20 0.47
ALPL P05186 1/20 0.47
GAA P10253 1/20 0.47
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171198 0.81 DRD2 (0.71) ALDH1A1TSHRSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6159875 0.80 HTR2A (0.54) HTR2AHTR2CSLC6A4SLC6A3HTR1A
SCHEMBL11123253 0.76 ALDH1A1 (0.61) ALDH1A1KDM4EHTTTSHRSMN1; SMN2
SCHEMBL6162560 0.75 DRD2 (0.45) SMN1; SMN2MAPTHTR1AGAADRD2
SCHEMBL25819265 0.74 GAA (0.57) ALDH1A1KDM4EHTTTSHRSMN1; SMN2
SCHEMBL6162708 0.73 L3MBTL1 (0.55) ALDH1A1KDM4ESMN1; SMN2HPGDGAA
SCHEMBL3436300 0.73 DRD2 (0.49) ALDH1A1HTTTSHRSMN1; SMN2MAPT
SCHEMBL8218392 0.72 HTR1A (0.67) ALDH1A1KDM4EHTTTSHRSMN1; SMN2
SCHEMBL4875267 0.72 ALDH1A1 (0.79) ALDH1A1KDM4ESMN1; SMN2MAPTHPGD
SCHEMBL7775626 0.72 HTR1A (0.77) ALDH1A1KDM4EHTTTSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed